Literature DB >> 18055212

Detection of ATP-binding to growth factors.

Simone König1, Anja Hasche, Stefanie Pallast, Josef Krieglstein, Susanne Klumpp.   

Abstract

It was shown in previous work that the interaction of growth factors (GFs) with adenosine triphosphate (ATP) is essential for their neuroprotective effect. Here we investigated the nature of the association of human basic fibroblast growth factor (bFGF), nerve growth factor (NGF), and brain-derived neurotrophic factor (BDNF) with ATP. It was demonstrated that this interaction involves the formation of non-covalent ATP-GF complexes that are labile at low pH and that could be selectively purified and subjected to electrospray and MALDI-TOF mass spectrometry. The results obtained with these techniques indicated that the stability of the complexes is high. Main features of the procedure used here are: (1) reversed-phase purification of nucleotide-protein non-covalent complexes, (2) their detection with MALDI-TOF-MS using acid-free matrix, and/or (3) their measurement with ESI-MS using soft desolvation conditions. The methodology was successful in providing proof for the presence of various nucleotide-GF complexes. It was extended to other nucleotide-binding proteins (ribonuclease A) as well as proteins that do not exhibit nucleotide binding (lysozyme) as positive and negative control, respectively. Thus, the method demonstrated its general use for the investigation of a wide range of proteins interacting with nucleotides as long as their complexes are sufficiently stable to accommodate the experimental conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055212     DOI: 10.1016/j.jasms.2007.10.010

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  18 in total

1.  Analysis of non-covalent protein complexes up to 290 kDa using electrospray ionization and ion trap mass spectrometry.

Authors:  Y Wang; M Schubert; A Ingendoh; J Franzen
Journal:  Rapid Commun Mass Spectrom       Date:  2000       Impact factor: 2.419

2.  Probing noncovalent protein-ligand interactions of the cGMP-dependent protein kinase using electrospray ionization time of flight mass spectrometry.

Authors:  Martijn W H Pinkse; Albert J R Heck; Klaus Rumpel; Frank Pullen
Journal:  J Am Soc Mass Spectrom       Date:  2004-10       Impact factor: 3.109

3.  Immunological studies on egg white proteins. IV. Immunochemical and physical studies of lysozyme.

Authors:  L R WETTER; H F DEUTSCH
Journal:  J Biol Chem       Date:  1951-09       Impact factor: 5.157

4.  Dissociation equilibrium constant of beta nerve growth factor.

Authors:  M A Bothwell; E M Shooter
Journal:  J Biol Chem       Date:  1977-12-10       Impact factor: 5.157

5.  Phosphorylation destabilizes the amino-terminal domain of enzyme I of the Escherichia coli phosphoenolpyruvate:sugar phosphotransferase system.

Authors:  N J Nosworthy; A Peterkofsky; S König; Y J Seok; R H Szczepanowski; A Ginsburg
Journal:  Biochemistry       Date:  1998-05-12       Impact factor: 3.162

6.  Selective extraction and characterization of a histidine-phosphorylated peptide using immobilized copper(II) ion affinity chromatography and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Scott Napper; Jason Kindrachuk; Douglas J H Olson; Stephen J Ambrose; Carmen Dereniwsky; Andrew R S Ross
Journal:  Anal Chem       Date:  2003-04-01       Impact factor: 6.986

7.  Phosphorylation of the growth factors bFGF, NGF and BDNF: a prerequisite for their biological activity.

Authors:  Susanne Klumpp; Dorothee Kriha; Gunther Bechmann; Alexander Maassen; Sandra Maier; Stefanie Pallast; Patrick Hoell; Josef Krieglstein
Journal:  Neurochem Int       Date:  2005-10-18       Impact factor: 3.921

8.  The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies.

Authors:  A Rattenholl; H Lilie; A Grossmann; A Stern; E Schwarz; R Rudolph
Journal:  Eur J Biochem       Date:  2001-06

9.  X-ray structure of the 154-amino-acid form of recombinant human basic fibroblast growth factor. comparison with the truncated 146-amino-acid form.

Authors:  J S Kastrup; E S Eriksson; H Dalbøge; H Flodgaard
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-03-01

10.  New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor.

Authors:  N Q McDonald; R Lapatto; J Murray-Rust; J Gunning; A Wlodawer; T L Blundell
Journal:  Nature       Date:  1991-12-05       Impact factor: 49.962

View more
  5 in total

1.  Mass spectrometry of protein-ligand complexes: enhanced gas-phase stability of ribonuclease-nucleotide complexes.

Authors:  Sheng Yin; Yongming Xie; Joseph A Loo
Journal:  J Am Soc Mass Spectrom       Date:  2008-05-28       Impact factor: 3.109

2.  Interaction of ATP with fibroblast growth factor 2: biochemical characterization and consequence for growth factor stability.

Authors:  Karsten Rose
Journal:  BMC Biochem       Date:  2011-03-29       Impact factor: 4.059

3.  Binding of ATP to vascular endothelial growth factor isoform VEGF-A165 is essential for inducing proliferation of human umbilical vein endothelial cells.

Authors:  Ronald E Gast; Simone König; Karsten Rose; Katja B Ferenz; Josef Krieglstein
Journal:  BMC Biochem       Date:  2011-05-27       Impact factor: 4.059

4.  Neural Stem Cells Rescue Cognitive and Motor Dysfunction in a Transgenic Model of Dementia with Lewy Bodies through a BDNF-Dependent Mechanism.

Authors:  Natalie R S Goldberg; Jacqueline Caesar; Ashley Park; Shawn Sedgh; Gilana Finogenov; Eliezer Masliah; Joy Davis; Mathew Blurton-Jones
Journal:  Stem Cell Reports       Date:  2015-10-17       Impact factor: 7.765

Review 5.  Small Endogenous Ligands Modulation of Nerve Growth Factor Bioactivity: A Structural Biology Overview.

Authors:  Francesca Paoletti; Doriano Lamba
Journal:  Cells       Date:  2021-12-08       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.